摘要
目的通过临床观察，探讨后房型有晶状体眼人工晶状体植入术治疗高度近视及散光的治疗效果，为，临床治疗提供更加安全性、有效的治疗参考。方法选择2010年7月至2013年5月进入我院进行高度近视及散光的患者98例，依照八院顺序的不同，随机将患者分为试验组（偶数组49例）、对照组（奇数组49例），分别选择后房型有晶状体眼人工晶收体植入术以及准分子激光角膜屈光术进行治疗，通过随访对比观察两组患者的治疗效果、并发症以及患者满意度。结果试验组患者接受手术治疗后视力恢复至O．5～1．O，对照组患者的视力水平同样恢复至O．5-1．0，然而总体恢复情况来看，两组相比差异明显，P〈O．05，具有统计学意义；试验组患者没有出现并发症，对照组患者出现白内障3例，眼压升高3例。两组相比，差异明显，P〈O．05，具有统计学意沁实验组患者的满意度要明显高于对照组。结论使用后房型有晶状体眼人工晶状体植入术治疗高度近视及散光不仅能够取得较好的手术治疗效果，还更加安全，值得临床大力推广应用。
Objective Through clinical observation, explore posterior chamber phakic intraocular lens implantation for high myopia and astigmatism treatment for clinical treatment to provide more security, and effective treatment for reference. Methods Chose from July 2010 to May 2013 into my hospital for high myopia and astigmatism in 98 patients, according to a different order of admission, patients were randomly divided into test group （even an array of 49 cases） and control group（odd array of 49 cases）, were selected posterior chamber phakic intraocular lens implantation and excimer laser corneal refractive surgery for treatment, through follow-up were observed comparing patient outcomes, complications, and patient satisfaction. Results Test group patients after surgical treatment to restore vision to 0.5 to 1.0 in the control group of patients with visual acuity recovered to 0.6 to 1.1, compared to the two groups no significant difference, P〉0.05, not statistically significant; experimental group were no concurrent disease, cataract patients in control group, 3 cases of glaucoma in 3 cases. Two groups, the difference was significant, P〈0.05, statistically significant; patient satisfaction experimental group was significantly higher. Conclusion Posterior chamber phakic intraocular lens implantation for high myopia and astigmatism can not only achieve better surgical outcomes, but also more secure, worthy of clinical application vigorously.
出处
《中国医药指南》
2014年第15期38-38,40,共2页
Guide of China Medicine
